| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |

Departments of Medicine (T.F., K.Sa., M.O., K.K., H.I., T.T., K.Sh.) and Surgery (Y.K.), Institute of Clinical Endocrinology, Tokyo Women's Medical College Kawada-cho 8-1
Research Institute of the Foundation for Growth Science in Japan (K.Sa., T.T., K.Sh.) Wakamatsu-cho, Sinjuku-ku, Tokyo, Japan
Address requests for reprints to: Kanji Sato, Institute of Clinical Endocrinology, Tokyo Women's Medical College, Kawada-cho 8-1, Shinjuku-ku, Tokyo 162, Japan.
Abstract
To elucidate the mechanism by which the low T3 and low T4 syndrome occurs in patients with infection, recombinant human interleukin-1 (IL-1) was administered to mice, and their thyroid hormone metabolism was studied.
Continuous sc infusion of IL-la or IL-1/8 at a dose of 0.015- 1 Mg/day for 3 days decreased food intake and serum T4, T3, and rT3 concentrations in a dose-dependent manner. In pair-fed control (PFC) mice, serum T4 and T3 also decreased, but rT3 was reciprocally increased. The T3/T4 ratio was greater in IL-1- treated mice than in PFC mice. Although food intake was decreased by 65% in IL-1-treated mice (1 /xg/day) compared with that in fed control mice, type I iodothyronine 5'-deiodinating activity in liver was significantly increased compared with that in fed control mice. Furthermore, the T3 and T4 responses to TSH were greatly diminished in IL-1-treated mice.
These findings suggest that IL-1 directly inhibited the effect of TSH on the thyroid gland and decreased the serum concentrations of T4 and T3, and that an increase in type I iodothyronine 5'-deiodinating activity in livers of IL-1-treated mice may account for the greater T3/T4 ratio and lower serum rT3 concentration than those in PFC mice. Since tumor necrosis factor-a has a similar effect, we speculate that both cytokines may be synergistically involved in the altered thyroid hormone metabolism in mice (decreased serum T4, T3) and rT3 concentrations) and hypercatabolism in a febrile state. (Endocrinology 124:167–174,1989)
Footnotes
* This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (61570563), a research grant from the Foundation for Growth Science in Japan, the Kato Memorial Trust for Nambyo Research, and a research grant from the U.S.-Japan Malnutrition Panel, 1987.
Present address: Third Department of Internal Medicine, Nagoya City University Medical School, Nagoya, Japan.
Received June 17, 1988.
This article has been cited by other articles:
![]() |
K. Sato, M. Ozawa, H. Demura, and T. Fujii Thyroid Function in the Acquired Immunodeficiency Syndrome (AIDS) Ann Intern Med, November 15, 1989; 111(10): 857 - 858. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |